The Improvements of Dietary Supplement of Black Rice on Metabolic Syndrome
IDSBRMS
1 other identifier
interventional
101
0 countries
N/A
Brief Summary
The purpose of this study is to thoroughly investigate how the interaction between black rice and human gut microbiota affects metabolic diseases, this study will recruit patients with Metabolic Syndrome (MS) and provide them with dietary supplementation of black rice (50 g/day) for 3 months to observe its effect on the development of MS. The focuses of this project are to elucidate how black rice consumption affects the composition and metabolism of intestinal bacteria as well as the development of MS, and to further analyze whether the changes in intestinal bacteria are associated with the changes in MS improvements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Jun 2014
Shorter than P25 for phase_2
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedFirst Submitted
Initial submission to the registry
March 26, 2015
CompletedFirst Posted
Study publicly available on registry
April 3, 2015
CompletedApril 3, 2015
March 1, 2015
6 months
March 26, 2015
April 2, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
reversal rate of metabolic syndrome
Numerator is number of people is metabolic syndrome at baseline but not after intervention. The denominator is the overall number of people in the group
3 months
Secondary Outcomes (2)
proportion of Bacteroides
3months
proportion of Bifidobacterium
3months
Other Outcomes (5)
changes in fasting blood-glucose
3 months
changes in fasting total triglyceride
3 months
changes in fasting HDL-c
3 months
- +2 more other outcomes
Study Arms (2)
black rice group
EXPERIMENTALEach subject in the experimental group will be provided with black rice (50 g/day).According to the clinical requirements, no specific rules are needed for other treatments of the two groups.
white rice group
PLACEBO COMPARATORindividuals in the control group will be subjected to follow-up. According to the clinical requirements, no specific rules are needed for other treatments of the two groups.
Interventions
They asked to keep their normal life style during intervention
They asked not to consume any black rice or excess amount of food rich in anthocyanin compared to their normal life style, such as grapes, blueberry, red wine, black bean during intervention.
Eligibility Criteria
You may qualify if:
- individuals meeting at least 3 of the following 5 criteria will be chosen:
- abdominal obesity: using the waist standard for Asians: waist≥90 for male and ≥80 for female
- high blood sugar: fasting plasma glucose≥5.6mmol/L (100mg/d L) or individuals diagnosed with diabetes and being treated
- hypertension: systolic blood pressure≥130 mm Hg or diastolic blood pressure≥85 mm Hg or individuals diagnosed with hypertension and being treated
- dyslipidemia: fasting total triglycerides≥1.70 mmol/L(150 mg/d L) or individuals undergoing lipid-lowering therapy
- fasting plasma high-density lipoprotein cholesterol\<1.03mmol/L (40mg/dL) for male or \<1.3mmol/L (50mg/dL) for female.
You may not qualify if:
- having current or former cardiovascular disease, including coronary heart disease (e.g., angina pectoris, myocardial infarction, coronary revascularization, abnormal Q waves in ECG), stroke (e.g., congestive, hemorrhagic, or transient ischemic stroke), and intermittent claudication caused by peripheral arterial diseases;
- severe clinical conditions that may compromise patients' participation in experiments, e.g., digestive diseases leading to inability to maintain black rice uptake, patients receiving parenteral nutrition supply, malignancies in progress, and mental illness;
- immunodeficiency disease or AIDS, chronic inflammation conditions
- drug abuse or alcoholism (\>80g/d).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ling wenhua, profess
Sun Yat-sen University
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD candidate
Study Record Dates
First Submitted
March 26, 2015
First Posted
April 3, 2015
Study Start
June 1, 2014
Primary Completion
December 1, 2014
Study Completion
December 1, 2014
Last Updated
April 3, 2015
Record last verified: 2015-03